Study of Ribosomal Protein P2 in Breast Cancer
Author Information
Author(s): M.G.F. Sharp, S.M. Adams, P. Elvin, R.A. Walker, W.J. Brammar, J.M. Varley
Primary Institution: University of Leicester
Hypothesis
The expression levels of ribosomal protein P2 mRNA differ between benign and malignant breast tumors.
Conclusion
The study found that P2 mRNA expression is significantly higher in benign fibroadenomas compared to malignant breast carcinomas.
Supporting Evidence
- The expression of P2 mRNA was significantly higher in seven fibroadenomas than in seven carcinomas.
- The average difference in expression was five-fold.
- Previous studies indicated that ribosomal proteins may play a role in tumor progression.
Takeaway
This study looked at a protein called P2 in breast tumors and found that it is more common in non-cancerous tumors than in cancerous ones.
Methodology
The study involved screening a cDNA library from breast carcinoma and comparing mRNA levels in fibroadenomas and carcinomas using Northern blotting.
Limitations
The study's sample size may not be large enough to generalize findings across all breast cancer types.
Participant Demographics
The study included samples from 49 patients with breast tumors and 47 individuals with normal tissue.
Statistical Information
P-Value
<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website